DGAP-Stimmrechtsanteile: STRATEC Biomedical AG

DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG

18.11.2016 18:02

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------------

Notification of Major Holdings

1. Details of issuer

STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Germany

2. Reason for notification

X Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights Other reason:

3. Details of person subject to the notification obligation

Name: City and country of registered office: Montanaro European Smaller Companies Dublin Ireland Public Limited Company

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.



5. Date on which threshold was crossed or reached

14 Nov 2016

6. Total positions

% of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 2.79 % 0 % 2.79 % 11859120 ing situat- ion Previo- 3.15 % n/a % n/a % / us notifi- cation

7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN absolute in % direct (Sec. indirect (Sec. direct (Sec. indirect 21 WpHG) 22 WpHG) 21 WpHG) (Sec. 22 WpHG) DE000STRA555 331000 0 2.79 % 0 % Total 331000 2.79 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % % Total %

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total %

8. Information in relation to the person subject to the notification obligation

X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights % of voting rights Total of both (if (if at least held 3% through instruments (if at least held 5% or more) at least held 5% or more) or more)

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting: Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:



18.11.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

--------------------------------------------------------------------------- Language: English Company: STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Germany Internet: www.stratec.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------